posted on 2020-07-07, 13:42authored byCassandra
J. Hatzipantelis, Yao Lu, Daisy L. Spark, Christopher J. Langmead, Gregory D. Stewart
The
orphan Gαs-coupled receptor GPR52 is expressed exclusively
in the brain, predominantly in circuitry relating to symptoms of neuropsychiatric
and cognitive disorders such as schizophrenia. While GPR52 agonists
have displayed antipsychotic and procognitive efficacy in murine models,
there remains limited evidence delineating the molecular mechanisms
of these effects. Indeed, previous studies have solely reported canonical
cAMP signaling and CREB phosphorylation downstream of GPR52 activation.
In the present study, we demonstrated that the synthetic GPR52 agonist,
3-BTBZ, equipotently induces cAMP accumulation, ERK1/2 phosphorylation,
and β-arrestin-1 and -2 recruitment in transfected HEK293T cells.
In cultured frontal cortical neurons, however, 3-BTBZ-induced ERK1/2
phosphorylation was significantly more potent than cAMP signaling,
with a more prolonged signaling profile than that in HEK293T cells.
Furthermore, knock down of β-arrestin-2 in frontal cortical
neurons abolished 3-BTBZ-induced ERK1/2 phosphorylation, but not cAMP
accumulation. These results suggest a β-arrestin-2-dependent
mechanism for GPR52-mediated ERK1/2 signaling, which may link to cognitive
function in vivo. Finally, these findings highlight
the context-dependence of GPCR signaling in recombinant cells and
neurons, offering new insights into translationally relevant GPR52
signaling mechanisms.